Mexico recorded 2,136 cases of dengue and four deaths between January and May 2026, according to the Secretary of Health [1, 3].
These figures provide the baseline for the government's current public health strategy. The data serves as a justification for the implementation of two different vaccines to curb the spread of the virus across the country [2, 3].
Health Secretary David Kershenobich said that 1,140 of the total cases reported through May presented signs of alarm [1]. Despite the fatalities, Kershenobich said the current situation reflects an improvement compared to the outbreaks recorded in 2024 and 2025 [2].
Earlier reports provided a narrower window of data. During the first three months of 2026, the disease extended to 24 states with 1,332 cases and three deaths [4]. The updated figures through May indicate a continued rise in infections as the season progresses.
"Entre enero y mayo de 2026 se han registrado 2 mil 136 casos de dengue en México, de los cuales mil 140 presentaron signos de alarma," Kershenobich said [1].
The Ministry of Health is using these trends to push for broader immunization. The focus remains on reducing the number of severe cases that require hospitalization, and those that result in death [2].
Officials continue to monitor the 24 states already impacted by the virus [4]. The government aims to prevent the caseload from reaching the peaks seen in previous years through a combination of vector control and the new vaccination drive [2].
“Mexico recorded 2,136 cases of dengue and four deaths between January and May 2026.”
The shift toward promoting two separate vaccines suggests that Mexican health authorities are moving from reactive containment to a proactive immunization strategy. By comparing current data to the higher spikes of 2024 and 2025, the government is attempting to demonstrate that while the virus remains endemic, the severity of the outbreaks is being managed more effectively.
